July 8 update: Pfizer Canada has made the decision to discontinue the manufacturing of both formats of DEMULENTM 30 (2 mg Ethynodiol Diacetate plus 0.03 mg Ethinyl Estradiol) tablets.
Pfizer Canada regrets to inform customers of a drug shortage situation for DEMULENTM 30 (2 mg Ethynodiol Diacetate plus 0.03 mg Ethinyl Estradiol) tablets.
Please note that ordering restrictions may apply to wholesalers during the product shortage. Pfizer will continue to closely monitor the ordering and selling patterns of customers during this period.
Pfizer recommends that patients consult a healthcare professional prior to establishing an alternative treatment.
.PDF%20-%20Adobe%20Acrobat.png)
Pfizer regrets any inconvenience that this situation may cause and would like to assure you that they are doing their utmost to resolve the situation.
For all inquiries including, medical information, allocations and general information related to this product please contact 1-800-387-4974.